Dentsply Sirona (XRAY) Misses Q4 EPS by 2c, provides guidance

Dentsply Sirona (NASDAQ: XRAY) reported Q4 EPS of $0.27, $0.02 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $961 million versus the consensus estimate of $927.6 million.

GUIDANCE:

Dentsply Sirona sees FY2026 EPS of $1.40-$1.50, versus the consensus of $1.50. Dentsply Sirona sees FY2026 revenue of $3.5-3.6 billion, versus the consensus of $3.674 billion.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Uranium Royalty Corp. sets shareholder vote on $1.14B Sweetwater deal
• Macquarie Downgrades Luk Fook Holdings International Ltd. (590:HK) (LKFLF) to Neutral